How Jintara treats ADHD and addiction together.

ADHD is a neurodevelopmental condition of inattention, impulsivity, and restlessness that begins in childhood and carries into adult life. That profile creates a real vulnerability to substances, and NIDA's research on comorbidity has documented substantially elevated rates of substance use disorder in adults with ADHD, with co-occurrence estimated at 25 to 50 percent across clinical populations. The overlap is large enough that clinicians treat the two as connected rather than coincidental.

The connection makes sense once you look at the mechanism. The same brain that struggles to hold attention, sit with boredom, and pause before acting is also the brain that responds fast and gratefully to a substance that quiets the noise. Addressing that underlying reality is part of what mental health treatment alongside addiction means at Jintara, where the neurological driver is treated rather than ignored. People with ADHD often describe the first time a substance made them feel focused, calm, or finally regulated, and that relief is exactly what makes the attachment so understandable.

This is why treating the addiction and leaving the ADHD untouched so often fails. If the substance was doing a job, taking it away without addressing the job leaves a gap the person will try to fill again.

Self-medication is the pattern where a person uses substances not for the high but to manage symptoms that are making ordinary life unworkable. For someone with undiagnosed ADHD, this usually happens with no awareness that ADHD is involved at all, a mechanism NIMH's overview of ADHD in adults describes in the way untreated symptoms drive risky coping. Alcohol slows the racing thoughts, stimulants sharpen concentration, and cannabis takes the edge off the constant irritability of sensory overload. Impulsivity also produces anger-like outbursts, so many clients benefit from the same anger management skills that sit inside our emotion regulation work. The substance works, at least at first, and the habit sets in long before anyone identifies the cause.

Many clients arrive at Jintara having managed undiagnosed ADHD for years. Some have leaned on stimulant addiction to push through the day, others on sedating substances to switch the noise off at night. When they stop, they are not just in withdrawal. They are losing the thing that was filling a neurological gap, which is why the early days feel so exposed, and understanding that difference is what separates treatment that holds from treatment that produces a fortnight of abstinence and a fast return to use.

Some clients arrive already diagnosed and certain. Others arrive with no ADHD history at all and receive that diagnosis for the first time in treatment, once the substance effects clear and their real baseline becomes visible.

Telling genuine ADHD apart from substance effects is one of the harder calls in dual diagnosis. A fair assessment needs time and a clear head, which is why Jintara's psychiatric assessment is led by a psychiatrist rather than a counsellor and continues once medical detox has resolved the acute withdrawal phase. Stimulants, alcohol, and cannabis all produce attention and impulsivity problems that look almost identical to ADHD, a diagnostic difficulty NIH MedlinePlus on ADHD sets out plainly. Rushing that call is how people get mislabelled.

The assessment covers substance history, mental health history, childhood development, and how the person presents day to day. Childhood onset is the clearest clue. ADHD that is genuinely present leaves a long trail of focus and organisation difficulty going back years, while substance-induced attention problems tend to arrive with the heavy use and ease when it stops.

If ADHD is confirmed, the plan is adjusted around it. If the symptoms clear with detox and turn out to be substance-induced rather than neurological, that finding is just as clinically important, and it shapes the therapy for the rest of the stay.

The structured environment of residential treatment is usually described as a practical necessity. For a client with ADHD it is one of the most therapeutic features of the whole program. External structure, written schedules, consistent routines, and clear expectations all carry the executive-function load that ADHD makes so heavy. When the program decides what happens next, the client can spend their available attention on the actual therapeutic work instead of on trying to organise the day.

The structure does more than keep order. Within it, cognitive behavioural therapy is adapted for clients where impulsivity and attention are in play, and Denise uses an ABC tool simple enough to run mentally rather than on a worksheet, which removes a barrier that trips up a lot of ADHD clients. The aim is not to erase ADHD but to build enough internal structure that the person can function once the external program is gone.

Practical strategies for life after discharge are introduced alongside the therapy: calendar systems, written routines, external accountability, and planning tools. These are not generic life advice. They are compensatory systems designed to work with the neurological profile rather than pretend it will change.

Growing up with undiagnosed ADHD tends to leave a residue. A childhood of being called lazy, careless, or not trying hard enough, of missed deadlines and social friction, accumulates into something heavier than the attention symptoms alone. By the time an adult reaches treatment, they often carry both the neurological features of ADHD and a real trauma history built on top of them. That combination shapes how the therapy is planned.

Not all of that responds to the same tool. For clients whose anxiety and low self-worth are rooted in specific unprocessed experiences, EMDR therapy can be effective, though it is not assigned automatically. EMDR is not standard for every admission. It is primarily relevant for clients staying eight weeks or more, it is introduced only after medical stabilisation, and four-week clients may not reach the processing stage.

The distinction matters for treatment. Some of what looks like ADHD in a trauma survivor is actually hypervigilance, dissociation, and difficulty concentrating under stress, an overlap SAMHSA's guidance on co-occurring disorders treats as common rather than exceptional. Accurate assessment separates the two, and both are treatable.

One of the most consistent findings in working with adults with ADHD is how much the shame gets in the way. A lifetime of being told they are not trying hard enough interferes with recovery as much as the attention symptoms do. That history is part of what gets examined in individual therapy sessions, where understanding that ADHD is a neurological difference rather than a character failure becomes the reframe that changes what recovery means and what is genuinely possible.

Each session helps the client build a clear picture of their own patterns: when impulsivity shows up, what sets off the distractibility, which emotional states drive the urge to use, and which external systems actually help them function. That picture becomes the foundation of the aftercare plan.

Denise draws on motivational interviewing alongside CBT, which suits ADHD presentations well. Motivational interviewing works by helping people find their own reasons for change rather than importing someone else's. For a person whose history is full of external pressure and repeated failure, that approach tends to produce better engagement and better retention.

Medication for ADHD in the context of addiction is one of the areas that asks the most of clinical judgement. Our medication protocols are discussed openly with each client during the assessment phase, so nothing about the plan is a surprise. Stimulant medicines such as methylphenidate and amphetamine-based compounds are effective for ADHD but carry a recognised risk for anyone with a history of stimulant misuse, a tension NIDA's guidance on prescription stimulants sets out directly. Any stimulant medication is therefore considered case by case, with the addiction history fully in view.

Non-stimulant options are part of the conversation where stimulant exposure is a concern. The point of the medication review is to treat confirmed ADHD and any other psychiatric presentation accurately, working with the on-site psychiatrist rather than reaching for a default.

One thing to be clear about. Jintara does not offer maintenance medication for addiction after detox. Methadone is used only during detox for an opioid withdrawal taper, never as ongoing maintenance. The medication work here is about treating what is actually present, not about swapping one substance for another.